PP
BHVN icon

PFS Partners’s Biohaven BHVN Stock Holding History

PFS Partners’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-4,000
Closed -$60K – 592
2025
Q3 		$60K Buy
+4,000
New +$58.2K 0.03% 158

Other funds holding BHVN

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RPSM
Royalty Pharma Sub-Manager New York $242M AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

PFS Partners's BHVN Position: Q4 2025 in Review

PFS Partners sold out of Biohaven (BHVN) in Q4 2025, closing a stake of 4,000 shares — an estimated $60K sold.

PFS Partners first reported a position in BHVN in Q3 2025 and held it in 1 quarter. The position peaked at $60K in Q3 2025. 273 funds tracked by Wall St. Rank hold BHVN as of Q4 2025.

  • PFS Partners reported no remaining Biohaven position as of Q4 2025 after selling out during the quarter.
  • PFS Partners sold 4,000 Biohaven shares in Q4 2025, an estimated $60K.
  • PFS Partners first reported a position in Biohaven in Q3 2025 and held it in 1 quarter.
  • PFS Partners's Biohaven position peaked at $60K in Q3 2025.
  • 273 funds tracked by Wall St. Rank held Biohaven as of Q4 2025.

Based on PFS Partners's 13F filing for Q4 2025, filed 16 Jan 2026.